Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Susumu, Sogabe"'
Autor:
Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, Yasuyuki Kawamoto, Satoshi Yuki, Susumu Sogabe, Ayumu Hosokawa, Kentaro Sawada, Osamu Muto, Naoki Izawa, Koji Nakashima, Yoshiki Horie, Masataka Yagisawa, Shinya Kajiura, Takayuki Ando, Yosuke Mitsuhashi, Yu Sunakawa, Yasuka Kikuchi, Yoshito Komatsu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Although initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibility of edoxaban witho
Externí odkaz:
https://doaj.org/article/920bd0892d904f39b7d402794cf1198e
Autor:
Hiroshi Nakatsumi, Yoshito Komatsu, Tetsuhito Muranaka, Satoshi Yuki, Yasuyuki Kawamoto, Kazuaki Harada, Masayoshi Dazai, Miki Tateyama, Yusuke Sasaki, Takuto Miyagishima, Yasushi Tsuji, Masaki Katagiri, Michio Nakamura, Susumu Sogabe, Kazuteru Hatanaka, Takashi Meguro, Tomoe Kobayashi, Atsushi Ishiguro, Osamu Muto, Yoshiaki Shindo, Masahito Kotaka, Takayuki Ando, Ryo Takagi, Naoya Sakamoto, Yu Sakata
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe first-line chemotherapy for patients with RAS and BRAF wild-type metastatic colorectal cancer (mCRC) commonly involves cytotoxic regimens, such as FOLFOX and FOLFIRI, combined with epidermal growth factor receptor (EGFR) antibodies. Whe
Externí odkaz:
https://doaj.org/article/aab8f05946ed4eb79d1f6def13b45094
Autor:
Naoya Sakamoto, Michio Nakamura, Isao Yokota, Yoshito Komatsu, Yasuyuki Kawamoto, Satoshi Yuki, Yasuo Takahashi, Yasushi Tsuji, Atsushi Sato, Shintaro Nakano, Kazuaki Harada, Takuto Miyagishima, Susumu Sogabe, Masayoshi Dazai, Atsushi Ishiguro, Shinya Kajiura, Miki Tateyama, Kazuteru Hatanaka, Takahide Sasaki, Yoshiaki Shindo, Tomoe Kobayashi, Yuh Sakata
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Introduction Combination chemotherapy with oxaliplatin, irinotecan, fluorouracil and leucovorin (FOLFIRINOX) has become one of the standard treatments for metastatic pancreatic cancer. However, the use of FOLFIRINOX requires prolonged infusion. There
Externí odkaz:
https://doaj.org/article/f88cfa70938b4b4aaef5a45e37270992
Autor:
Yusuke Tomita, Hideyuki Seki, Emi Matsuzono, Yoshimitsu Kobayashi, Susumu Sogabe, Nozomu Sugai, Jun Fujita, Akira Suzuki
Publikováno v:
DEN Open, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Early gastric mixed neuroendocrine‐non‐neuroendocrine neoplasms (MiNENs) are rare diseases, with no data on their incidence and prognosis. We report the case of intramucosal gastric MiNENs for endoscopic submucosal dissection (ESD) treat
Externí odkaz:
https://doaj.org/article/d71cfb887a5e49ad870bb5699c09036b
Autor:
Yasuyuki Kawamoto, Yoshito Komatsu, Satoshi Yuki, Kentaro Sawada, Tetsuhito Muranaka, Kazuaki Harada, Hiroshi Nakatsumi, Hiraku Fukushima, Atsushi Ishiguro, Masayoshi Dazai, Kazuteru Hatanaka, Michio Nakamura, Ichiro Iwanaga, Minoru Uebayashi, Susumu Sogabe, Yoshimitsu Kobayashi, Takuto Miyagishima, Kota Ono, Naoya Sakamoto, Yuh Sakata
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background In Japan, S-1 plus cisplatin (SP) regimen has become a standard therapy for patients with advanced gastric cancer. Moreover, the S-1 plus oxaliplatin regimen is now a standard treatment. Nab-paclitaxel was developed for chemothera
Externí odkaz:
https://doaj.org/article/5eb50e1555324189bdb9aa9a907bc4f0
Autor:
Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Michio Nakamura, Osamu Muto, Susumu Sogabe, Yoshiaki Shindo, Atsushi Ishiguro, Atsushi Sato, Yasushi Tsuji, Masayoshi Dazai, Hiroyuki Okuda, Takashi Meguro, Kazuaki Harada, Mari Sekiguchi, Kazufumi Okada, Yoichi M Ito, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
The Oncologist. 27(8):e642-e649
Background Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cc69eba2d426282aed725eb5ff31f5
http://hdl.handle.net/2115/86546
http://hdl.handle.net/2115/86546
Autor:
Kazuaki Harada, Takahiro Yamamura, Osamu Muto, Michio Nakamura, Susumu Sogabe, Kentaro Sawada, Shintaro Nakano, Masataka Yagisawa, Tetsuhito Muranaka, Masayoshi Dazai, Miki Tateyama, Yoshimitsu Kobayashi, Sosuke Kato, Kazuteru Hatanaka, Yasuyuki Kawamoto, Satoshi Yuki, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 4
Pages: 1596
Volume 12
Issue 4
Pages: 1596
The effects of UGT1A1 gene polymorphisms or prior irinotecan treatment on treatment outcomes of nanoliposomal-irinotecan plus 5-fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with unresectable pancreatic ductal adenocarcinoma (PDAC) are not es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58106ec075031a2c6524330ed102f519
Autor:
Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, Yasuyuki Kawamoto, Satoshi Yuki, Susumu Sogabe, Ayumu Hosokawa, Kentaro Sawada, Osamu Muto, Naoki Izawa, Koji Nakashima, Yoshiki Horie, Masataka Yagisawa, Shinya Kajiura, Takayuki Ando, Yosuke Mitsuhashi, Yu Sunakawa, Yasuka Kikuchi, Yoshito Komatsu
BackgroundAlthough an initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibility of edoxaban without init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f3d8454f597a761d24462700b32bf3
https://doi.org/10.21203/rs.3.rs-1059233/v1
https://doi.org/10.21203/rs.3.rs-1059233/v1
Autor:
Kentaro Sawada, Yasushi Tsuji, Yoshito Komatsu, Susumu Sogabe, Masayoshi Dazai, Takuto Miyagishima, Yoshimitsu Kobayashi, Atsushi Ishiguro, Yasuyuki Kawamoto, Kazuaki Harada, Yuki Satoshi, Masataka Yagisawa, Tetsuhito Muranaka, Michio Nakamura, Yasuka Kikuchi
Purpose We previously reported that the periodic premedication of glucocorticoids during chemotherapy for gastrointestinal cancer (GIC) caused the reduction of bone mineral densities (BMD) (ESPRESSO-01). We conducted this study to evaluate the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55e97ae7e8d38c19829bb72a54dc46fc
https://doi.org/10.21203/rs.3.rs-993391/v1
https://doi.org/10.21203/rs.3.rs-993391/v1
Autor:
Chiho Sugisawa, Jun Saito, Seiich Tawara, Mitsuhide Naruse, Hiroshi Akahori, Susumu Sogabe, Ken-Ichi Kaneko, Kiyoto Shiga, Yutaka Oki, Takayuki Katabami, Noriko Kimura, Kazuhiro Takekoshi, Takafumi Yamashita
Publikováno v:
Endocrine pathology. 32(4)
Paragangliomas (PGLs) are neural-crest-derived, non-epithelial neuroendocrine tumors distributed along the parasympathetic and sympathetic nerves. Head-and-neck PGLs (HNPGLs) have been recognized as nonchromaffin, nonfunctional, parasympathetic tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c49f9e5208bbe4479aa3926ed2350a
https://pubmed.ncbi.nlm.nih.gov/34743284
https://pubmed.ncbi.nlm.nih.gov/34743284